Karen Deborah Chagin - Jun 9, 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role: Chief Medical Officer
Signature: /s/ Alex Levit, Attorney-in-Fact
Stock symbol: CNTX
Transactions as of: Jun 9, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/9/2025, 05:22 PM
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Chagin Karen Deborah	Chief Medical Officer	2001 MARKET ST, SUITE 3915 UNIT #15, PHILADELPHIA	/s/ Alex Levit, Attorney-in-Fact	2025-06-09	0002070710

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNTX	Stock Option (right to buy)	Award	$0	+153K		$0.00	153K	Jun 9, 2025	Common Stock	153K	$0.70	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on June 9, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.